Molecular biomarkers for hypoxia and thrombosis
thrombosis, hypoxia
THROMBOSIS, HYPOXIA, GROUP B
The levels of hypoxia and thrombosis biomarkers, HIF-1α and vWF were tested. The level of HIF-1α significantly decreased in Group A after treatment (AT) (Table vWF, a molecular marker of thrombosis induced by HIF-1α, was undetectable in a large number of patients either before and/or after the treatment. The samples included in the analysis were Group A, Furthermore, to see the difference between groups we conducted a comparative analysis of the biochemical, hematological parameters, and molecular markers at baseline (referred to as "Before Treatment") and After Treatment. We observed that MCP-1 was significantly higher in Group C as compared to Group B at baseline (Table 